Hexa PR Wire · Trusted Press Release Distribution

Michelle Gomes Discusses Evaheld And Modern Memorials — The Michael Peres Podcast

Hexa PR Wire · Press Release
2 min read
On this page
  1. About Michelle Gomes
  2. About Michael Peres
  3. About The Michael Peres Podcast

Michelle Gomes, co-founder and CEO of Evaheld, joined The Michael Peres Podcast to discuss “health-meets-death tech,” legacy planning, and how capturing stories and advance-care wishes before crisis supports families and care providers. The episode traced Evaheld’s origins in personal loss and years of volunteering, then reviewed how secure legacy vaults, guided video prompts, and modern memorials help preserve values and decisions with privacy and compliance in mind. Gomes also outlined practical steps for advance-care planning, partnering with providers and insurers, and simple frameworks families can use to start recording today.

About Michelle Gomes

Michelle Gomes is the co-founder and CEO of Evaheld, an Australian platform that helps people preserve stories, values, and advance-care wishes through secure legacy vaults and memorial tools. Evaheld works with families, providers, and insurers to align empathy with compliance and digital readiness.

About Michael Peres

Michael Peres is a serial entrepreneur, software engineer, journalist, and author. He has founded media and technology ventures, holds degrees in computer science, mathematics, and Jewish studies, and is pursuing biomedical engineering. Peres founded Hexa PR Wire and serves as Chief Editor for several publications.

About The Michael Peres Podcast

The Michael Peres Podcast features conversations on science, technology, society, entrepreneurship, and current events, presented in a concise, journalistic format.

Contact Information

Michelle Gomes: Email

AnswersFrequently asked questions

More press releases

The Peptide Research Finding That Failed Its Second Test: Why Independent Replication Matters More Than a Promising First Result

The Peptide Research Finding That Failed Its Second Test: Why Independent Replication Matters More Than a Promising First Result

Two Laboratory Reports, One Peptide Sample, Different Purity Results: What Researchers Should Investigate Before Trusting Either Number

Two Laboratory Reports, One Peptide Sample, Different Purity Results: What Researchers Should Investigate Before Trusting Either Number

Elijah Ladapo: Why Successful Entertainment Franchises Need More Than a Great Story

Elijah Ladapo: Why Successful Entertainment Franchises Need More Than a Great Story

The Laboratory Rejected the Shipment After Delivery: Why Small Research Suppliers Need a Documented Exception Process

The Laboratory Rejected the Shipment After Delivery: Why Small Research Suppliers Need a Documented Exception Process

The Peptide Study Was Published, but Its Scientific Record Changed: Why Corrections, Retractions and Updated Evidence Matter

The Peptide Study Was Published, but Its Scientific Record Changed: Why Corrections, Retractions and Updated Evidence Matter

The Peptide Study Started With 100 Samples, but Only 64 Reached the Final Chart: How Missing Data Can Change a Scientific Result

The Peptide Study Started With 100 Samples, but Only 64 Reached the Final Chart: How Missing Data Can Change a Scientific Result

Orthopedic Marketing Starts With the Symptoms Patients Actually Describe

Orthopedic Marketing Starts With the Symptoms Patients Actually Describe

The Research Sample That Cleared Customs but Lost Its Scientific Identity: Why Documentation Gaps Complicate Laboratory Procurement in Central America

The Research Sample That Cleared Customs but Lost Its Scientific Identity: Why Documentation Gaps Complicate Laboratory Procurement in Central America